Business Segments · Percent of Gross Trade Receivables

Pharmaceutical and Specialty Solutions — Percent of Gross Trade Receivables

Cardinal Health Pharmaceutical and Specialty Solutions — Percent of Gross Trade Receivables increased by 18.2% to 26.0% in Q2 2025 compared to the prior quarter. This increase may warrant attention — for this metric, lower values are generally preferred.

Analysis

StatementSegment
CategoryLiquidity
SignalLower is better
VolatilityModerate
First reportedQ2 2023
Last reportedQ2 2025

How to read this metric

An increase may signal potential credit risk or slower payment cycles, while a decrease suggests improved liquidity and faster cash conversion.

Detailed definition

This metric measures the portion of total gross trade receivables attributed to specific customer segments or entities w...

Peer comparison

Comparable to 'Accounts Receivable Concentration' metrics found in the financial disclosures of large-scale healthcare distributors.

Metric ID: cah_segment_pharmaceutical_and_specialty_solutions_percent_of_gross_trade_receivables

Historical Data

3 periods
 Q2 '23Q2 '24Q2 '25
Value23%22%26%
QoQ Change-4.3%+18.2%
YoY Change-4.3%+18.2%
Range22%26%
Avg YoY Growth+6.9%
Median YoY Growth+6.9%

Frequently Asked Questions

What is Cardinal Health's pharmaceutical and specialty solutions — percent of gross trade receivables?
Cardinal Health (CAH) reported pharmaceutical and specialty solutions — percent of gross trade receivables of 26.0% in Q2 2025.
What does pharmaceutical and specialty solutions — percent of gross trade receivables mean?
The share of total outstanding customer payments owed to the segment from a specific group.